Chapter 1	Ordination and receptionist
Chapter 2	Content and validity of the Receptor
Chapter 3	Electronic, telephone and telefax receptacles
Chapter 4	Foreign prescriptions
Chapter 5	Reception Dispatch
Chapter 6	Retention and reporting of medicinal products which are eup-acting medicinal products
Chapter 7	Medicine Requests
Chapter 8	Delivery Groups
Chapter 9	Revocation, non-security for payment and dispensation
Chapter 10	Punishment and entry into force
Appendix 1	Appendix 1 contains a list of groups of medicinal products which may be substituted at the level of the medicinal product for the medicinal product, cf. § 38 and § 40
Appendix 2	Appendix 2 contains a list of groups of medicinal products which may be substituted for each other, cf. § 38
Appendix 3	Substances which, without being included in Appendix B of Annex 1 to the Executive Order for the Euphoria are included, are covered by Section 65 (5) of the Concierent Notice. 2

Publication about prescriptions 1)

In accordance with section 38 (4), Paragraph 1, section 42, paragraph. 2-4, and section 72, paragraph. 2, in the case of apothecary, cf. Law Order no. 855 of 4. August 2008, as amended by law no. 465 of 18. May 2011, section 61, paragraph. 2-3 and § 62, in the Law no. 1180 of 12. In December 2005 on medicinal products, as amended by Section 1 of Act 1. 1557 of 20. December 2006 :

Chapter 1

Ordination and receptionist

§ 1. A prescription means a copy (ordination) by a doctor, a dentist or a veterinarian for the supply of medicinal products from a pharmacy or a transcript of a veterinary medicinal product on the supply of medicinal products from a holder of a permit in accordance with paragraph 39, paragraph 1. 1, in the case of medicinal products for the use of medicinal products for the production of animals for production.

Paragraph 2. A prescription shall also mean a written ordination (order ' s) from a doctor, dentist or veterinary physician on the supply of gas to medical use from a pharmacy or by holder of a licence for retailor for gas to be used for medicinal purposes ; using, cf. § 39, paragraph. 1, in the law on medicinal products. The requirements for the design and conditions of storage and delivery conditions for such a prescription (order slip) are shown by the announcement of gas for medical use.

Paragraph 3. Ordination can be done in writing, electronically, telefax or telephone.

Paragraph 4. Doctors and dentists may, as part of their establishment, prescribe medicinal products for use by certain persons, in practice or for their own use. Doctors authorised by the apothecary Act, section 8, may also prescribe prescribe medicinal products for further extradition. Veterinary physicians may prescribe medicinal products for use in particular animals for use in practical terms or on further extradition.

Paragraph 5. A prescription may be used by the ordinary doctor to notify the dispensary that one of the doctor previously prescribed medicinal product that is dosed must be given a sepl.

§ 2. In determining which medicinal products are to be subject to prescription, particular attention shall be paid to the medicinal products,

1) directly or indirectly may cause a health hazard, even in normal use, if they are used without medical supervision,

2) directly or indirectly present health hazard, because they are frequently used and are used incorrectly,

3) contains substances or preparations whose effect or adverse effects are necessary to monitor, or

4) they must be submitted in the centre of the parental (injected or similar).

Paragraph 2. Medicinal products for food-producing animals are prescription-only unless the following conditions are met :

1) the administration of the medicinal product shall be limited to formulations where the use does not require specific knowledge or skills ;

2) the medicinal product does not constitute a direct or indirect risk to treated animals, for persons who submit the medicinal product or the environment, even if the medicinal product is administered incorrectly,

3) the product of the medicinal product does not contain any warnings about any serious adverse reactions to the correct use,

4) neither the medicinal product or any other medicinal product with the same active substance has previously been the subject of frequent reports of serious adverse reactions ;

5) the product summary does not provide information on contraindications in relation to other medicinal products for animals normally used without a prescription,

6) the medicinal product does not require special storage conditions ;

7) residues in food produced from treated animals do not present a risk to consumer safety, even if the medicinal product is used incorrectly, and

8) that there is no risk to human or animal health as regards the development of resistance to antimicrobials or anthelmintica, even if medicines containing these substances are not used incorrectly.

Paragraph 3. Medicinal awards are shown whether a medicinal product is prescriptionable, and whether it is subject to special surveillance, cf. § 4.

§ 3. Regardless of the provision in section 2 (2), 1, the following medicinal products are always prescription-only :

1) Magistrelle medicines.

2) Medicinal products for which no marketing authorisation has been issued.

3) Medicinal products for which marketing authorisation is requested and which contains a new medicinal product whose use has been approved for less than five years.

§ 4. For the determination of medicinal products to be subject to special surveillance, cf. Section 15 and section 63 shall pay particular attention to the means of the medicinal products ;

1) contains eup-forisining substances listed in Appendix B of Annex 1 to the publication of eeuphoria substances, in quantities not exempted from the provisions of that notice ;

2) by non-regulatory use may be associated with the risk of abuse and dependency, or

3) contains substances with new or special features which, for safety reasons, should be covered by special surveillance.

Chapter 2

Content and validity of the Receptor

Common rules for medical, dentistry and veterinary ecepter

§ 5. A prescription must be read clearly and legibly. It may not contain abbreviations or signs that make the understanding questionable or dependent on agreements between the receptor and the pharmacy or the holder of the person in paragraph 1 (1). 1, mentioned permission.

Paragraph 2. A prescription must contain only the information required by this notice and any other information necessary for the expedition of the prescription at the pharmacy or the holder of the prescribed in section 1 (3). 1, mentioned permission.

Paragraph 3. A prescription must not be composed of several sheets. However, this does not apply to telephone receptees.

§ 6. A prescription must contain

1) the date of issue,

2) the signature and signature of the receptor ; and

3) printed or stamped information on the name, position, address and telephone number of the receptor.

Paragraph 2. A prescription for medicinal products for its own use must include the endorsement : 'For its own use'.

Paragraph 3. A prescription for medicinal products for use in the prescription of the receptionist must include the endorsement : 'For use in practice'.

§ 7. A prescription for a medicinal product which has been granted marketing authorisation shall contain the name of the medicinal product, the medicinal product, strength (if the medicinal product is available in several strengths) and quantity. The strength and quantity must be shown uniquely and in such a way as to make changes not possible. The receptissuer may indicate that it must not be permitted to be deviated from the point of view, cf. Section 31 (1). 2.

Paragraph 2. A prescription for a medicinal product to be dosed must contain the provisions of section 7 (3). ONE, ONE. Act. the information and the endorsement ' dosage dispensation `. The quantity can be specified as a time period of two years at the most of two years, which shall be subject to a continuous dose of doses. If the prescription originator has a copy of the copy, the pharmacy shall send a copy of the dosage card to the prescription issuer.

Paragraph 3. If the provisioning of a medicinal product to be dosed, must be terminated, the prescription shall contain the provisions in section 7 (3). TWO, ONE. Act. the information referred to and the endorsement shall be ' sepated `. Unless otherwise indicated on the prescription, the sepcomponent shall be effected with effect from first future extradition.

Paragraph 4. A prescription for a magus medicinal product shall indicate the composition of the medicinal product, the requirements of the medicinal product and the quantity of the medicinal product concerned. The quantity must be shown uniquely and in such a way as to make changes not possible.

§ 8. A prescription must contain information about the indication, the dosage and possible relevant uses. The dosage is set by per. time and number of times per Time unit (day, day, week days, month e.l. ). The reference to the prescription must be easy to understand.

Paragraph 2. If a medicinal product is provided in a non-normal dose, the dose shall be stressed or expressed in terms of both numbers and letters. The use of a medicinal product for the non-usual use of the word is to be emphasised.

Paragraph 3. The receptor can hand over a written dosage guidance instead of leading the dosage on the prescription. The prescription shall be entered in such a case : ' Dosage by writing '.

Paragraph 4. The provision in paragraph 1 shall be Paragraph 1 shall not apply to prescriptions for personal use, to use in practice, or to pass on transmission and to prescriptions for which a dose-dispensed medicinal product is to be terminated.

§ 9. Any information on how many times and with which spaces a medicinal product may be extradiated must be given immediately during the ordination the information pertains to. The information must be easy to understand.

§ 10. A prescription is valid for two years after the issue is issued. However, a prescription issued by a doctor in the regional security system is only valid for 7 days after the issue is issued.

Paragraph 2. However, at the approval of a prescription, the receptor may indicate that its validity should be discontinued at an earlier stage.

Medical and dentists ' ecepter

§ 11. Medicinal and dentists are to be written to the front desk forms, drawn up by the Salary Salary of the Regions, in cooperation with the Board of Health, unless special conditions prevent this from being made, cf. however, section 15 (3). 1.

Paragraph 2. The information referred to in section 6-9 and section 12 to 15 mentioned must be entered directly on the prescription form. The receptissuer must not impose the labels on the prescription label.

§ 12. A doctor or dentist shall contain the following information, if the receptor is in possession of the name or number of the person concerned :

1) In the case of doctors, special medical term and external number or sickness-sharing code.

2) In the case of dentists, the Outer Number.

3) In the case of both the layers and the dentists, the authorization ID is :

§ 13. All electronic and signed-issued physician and dentists must be denoted indicative and dosage respectively to the extent that they are shown in the electronic version of Medicinal Prices.

§ 14. A prescription must contain information about the name, address and CPR no. from the person the medicinal product is ordainated to or sepated from. If the person ' s CPR # may not be obtained, in exceptional cases : ' Can not be obtained '. If the person has not been assigned a CPR no. Enter "Not Assigned".

Paragraph 2. If a child less than 16 years is not yet provided with a health insurance certificate, one of the parent ' s CPR (s) is not yet provided. and the child's birth date, whether or not the child has been assigned CPR no.

Paragraph 3. If a medicinal product that is not provided with warning that it may be reduced to the driving vehicle or the operating of dangerous machinery, cf. The notification of the labelling of medicinal products must bear the warning symbol immediately below the ordination.

§ 15. A doctor or dentist must be prescribed by a medicinal product which, in accordance with section 4, is subject to particular surveillance, indicate or disclose the CPR No, unless the ordination occurs by an electronic prescription. If the ordination does not occur in an electronic prescription and the prescription doctor or dentist does not wish to inform his CPR no, the prescribed prescription form shall be written on a special health management board.

Paragraph 2. Quantity and strength must be indicated by both numbers and letters, cf. however, section 20 (2), 3.

Paragraph 3. There must be only one ordination on each prescription.

Paragraph 4. At the ordination of methadone to patients for long-term treatment, the number of times the medicinal product may be extradicated can be extended. However, a maximum of 1 month shall be prescribed. The order must be made available or transferred as an electronic prescription. In addition to the requirements which are also applicable to telephone or electronic prescriptions, the receptacles must include the doctor's contact phone number.

Grower Eepter

§ 16. A veterinarian's record shall contain the following information, cf. however, paragraph 1 2 :

1) Authorization number of the vet.

2) The owner's owner's name and address.

3) Animal species.

4) Code for animal species, age group and ordination group, cf. the notification of the reporting of information to the statistics on medicinal products.

Paragraph 2. In the practice of medicinal products for use in animal doctor ' s practice, the prescription must include the following information :

1) Authorization number of the vet.

2) Praxscode.

§ 17. If an apothecary reserved for medicinal products is to be used for the treatment of animals kept for commercial purposes, the prescription shall be entered : ' Occupation '.

Paragraph 2. If a medicinal product has been included in the medicine prices during the delivery group, premix "," APC "or" BPK ", must be applied to the processing of production animals :" To production animals ".

Paragraph 3. If a medicinal product is to be used for the treatment of animals in the animal unit with a CHR number, the prescription must include the CHR number.

Paragraph 4. If a medicinal product is to be used for the treatment of animals whose meat or products are used for human consumption, the prescription must contain detention times, if it is a question of :

1) a medicinal product for animals approved for another animal species or used in an unauthorised dose ;

2) a medicinal product approved for human beings ; or

3) It's a magic drug.

§ 18. Expedited prescriptions on medicinal products for animals or a copy of the prescriptions shall be kept at the pharmacy or holder of the person in paragraph 1 (1). 1, mentioned permission for 5 years.

Paragraph 2. If a prescription expires several times, a copy of the prescription must be made in connection with each expedition.

Chapter 3

Electronic, telephone and telefax receptacles

§ 19. Electronic, telephone and telefax receptacles must be replaced by the following in Chapter 2.

Paragraph 2. I don't want veterinarians to use electronic prescriptions.

Paragraph 3. The Ordination of Magistrelle medicinal products must not be carried out by electronic prescription.

20. Electronic prescriptions are stored for two years at the prescription server in the Human Electronic Medicine Profiers ' PE.

Paragraph 2. The clerk ' s handwritten signature may be omitted on electronic prescriptions.

Paragraph 3. Indication of the quantity and strength of letters may be omitted on electronic prescriptions, cf. Section 15 (3). 2.

Paragraph 4. An ordinary doctor or dentist can cancel an electronic prescription that is not fully resolved at the prescription server in the Human Electronic Medicinal Propric Medical (Dialthcare) Medical Protection Agency.

Paragraph 5. It must be indicated in an electronic prescription, which computer system the prescription originator uses.

Paragraph 6. Systems for the transfer of electronic prescriptions shall be designed in such a way that the receptor has security to ensure that the prescriptions are transferred unchanged to the prescription server in the Human Electronic Medicinal Electronic Medicines (Health Management).

§ 21. The patient may request a list of ordinations that have not been provided. If the CPR number of the receptout is available. appear from the prescription, this information must not appear in the view.

§ 22. A telefax prescription may be transferred to the pharmacy only to the pharmacy or to the holder of the optional section of the section in section 1 (1). 1, mentioned permission from the receptor, cf. however, section 24.

Paragraph 2. A telefax prescription must be clearly marked by the prescription-issued receptacle : "Telefax prescription."

Paragraph 3. A telefax prescription from a doctor or dentist must be replaced by the prescription form referred to in section 11.

-23. Reception of prescriptions can only be performed by doctors, dentists and veterinarians personally.

Paragraph 2. The receptor must provide all the information required for written prescriptions for the receptor.

Paragraph 3. Reception of prescriptions should only happen when special conditions speak for it.

Paragraph 4. A copy of telephone receptees on medicinal products for human beings must be kept at the pharmacy for three months.

Paragraph 5. A copy of telephone prescriptions on medicinal products for animals shall be kept at the pharmacy or holder of the person in paragraph 1 (1). 1, mentioned permission for 5 years.

§ 24. A fax or telephone prescription may be used in specific cases where the patient is indifferent to the patient transfer from one pharmacy to another.

Paragraph 2. The dispensary that transfers a prescription to another pharmacy must be able to document the course of action and the reasons for the transfer. The dispensary that receives the prescription must show special vigilance in connection with the expedition of the prescription.

Paragraph 3. An electronic prescription that has not been disputed can be returned to the receptserver in the Human Electronic Medicinal Electronic Medicines (Health Management) Medical Exament.

Chapter 4

Foreign prescriptions

§ 25. Recepter issued by doctors, dentists or veterinarians who are authorized in an EU country, Norway or Iceland, without having received authorization in Denmark during a temporary residence in this country, the orthodontist or veterinary medicinal product is authorized, subject to the provisions of this notice.

Paragraph 2. Recepter issued by doctors or dentists authorised in an EU country, Norway or Iceland shall be subject to the provisions of this notice. The following provisions shall also apply :

1) Recepter on the medicinal products referred to in section 4 must not be dispoted.

2) The receptors must not be incapsused.

Chapter 5

Reception Dispatch

SECTION 26. The chemist and the holder of the one in section 1 (1). The authorization shall be subject to prescription-only medicinal products only when a valid prescription is available.

Paragraph 2. However, the pharmacy may supply a prescription medicinal product which is synonymous with the prescribed medicinal product, if :

1) the pharmacy does not have the prescribed medicinal product on stock ; and

2) the patient may be presumed to suffer severe health damage if the synonym medicinal product is not extradite and the treatment of the patient is therefore exposed.

§ 27. The apothecary and the holder of the one in section 1 (1). The said authorisation must organize workflows and routines at the pharmacy and on the company address of the authorisation holder in such a way as to ensure that there is sound control and security for,

1) the receptees that express their express are drawn up in accordance with the rules laid down in Chapter 2 to 4,

2) the identification of the strength, the dosage and the scope of application are deemed to be correct and that any interaction issues are clarified ;

3) the prescription is to be displeted and the medicinal products marked in accordance with the prescriptions ' s instructions and the requirements of this notice ; and

4) the Customer may, as necessary, be weighted on the use of medicinal products, etc.,

Paragraph 2. The apothecary and the holder of the one in section 1 (1). The authorisation shall draw up a instructions describing workflows, skills conditions, etc. in connection with the reception and the expedition of prescriptions and the provision of prescription prescribed medicinal products.

Paragraph 3. The apothecary and the holder of the one in section 1 (1). The said permit must ensure that workflows and routines allow for at least three months after the expedition of a prescription may be clarified who has contributed to the operation referred to in paragraph 1. 1, no. One, two, and three, mentioned control.

Paragraph 4. The apothecary and the holder of the one in section 1 (1). The said authorization shall ensure that the staff carrying out receptive expedition shall be carried out in accordance with paragraph 1. 1 and 3, cf. the announcement of pharmacies and apothecary staff and proclamations on the negotiation of medicinal products to production animals outside the pharmacy, in the course of basic training and continuing training, may be responsible for the task.

§ 28. If a prescription is not drawn up in accordance with the provisions of Chapter 2 to 4, except for section 12, no. 3, the pharmacy and the holder of the one in section 1 (1). 1, the permission referred to above shall be subject to the request.

Paragraph 2. If there is no possibility of malfunction and undispuuated or dispuated, the pharmacy and the holder of the person referred to in paragraph 1 (2) shall be determined. 1, do not allow the prescription to be provided unless there is no reasonable doubt as to which the prescription originator has requested to give the prescription. The pharmacy must also be allowed to expand the prescription if the patient is to be liable to suffer severe health damage if the medicinal product is not released and the treatment of the patient must therefore be suspended.

Paragraph 3. The chemist and the holder of the one in section 1 (1). The authorisation shall be able to document the establishment in accordance with paragraph 1. 1 and 2. The documentation must be kept for two years, for five years, in the case of the supply of medicinal products for animals, in accordance with the case of animals for animals. Section 18 (2). 1, in the pharmacy. The holder of the one in section 1 (1). 1, the permission referred to in the company address of the company (main address) shall keep the records for five years, cf. Section 18 (2). 1.

§ 29. The pharmacy should inform the receptor as soon as possible or, if there is no prescription, the patient ' s doctor, if the pharmacy is available ;

1) provide a different medicinal product other than the prescribed, cf. Section 26 (1). 2,

2) excludes a prescription in cases where it has not been possible to have errors and have no remedies or doubt clarified, cf. § 28, paragraph 1. 2 or

3) on the other basis, where necessary for the sake of the health of the patient, a prescription medicinal product shall be provided without a valid, defect and unambiguous prescription.

Paragraph 2. The holder of the one in section 1 (1). The authorization shall inform the receptor as soon as possible if the holder dispels a prescription in cases where it has not been possible to obtain errors and has been undispuable and disputing or disputing, cf. § 28, paragraph 1. TWO, ONE. Act.

Paragraph 3. The chemist and the holder of the one in section 1 (1). The authorisation shall be able to document the information referred to in paragraph 1. Paragraph 1 and paragraph. 2 mentioned expeditions. The documentation must be kept for two years, however, for five years in the case of the supply of medicinal products for animals, cf. Section 18 (2). 1, in the pharmacy. The holder of the one in section 1 (1). 1, the permission referred to in the company address of the company (main address) shall keep the records for five years, cf. Section 18 (2). 1.

-$30. If an apothecary is aware that several prescriptions are prescribing medicinal products to the same patient, and this may involve health risks to the patient, the pharmacy may inform the prescription of the dispensary of a prescription, including if : the name of the receptor, the name of the patient, the name of the patient, and the name, strength and dosage of the medicinal product.

Paragraph 2. The pharmacy must be able to document the course of action and the justification for the fact that the prescription of the receptors has been informed of the expedition.

§ 31. The chemist and the holder of the one in section 1 (1). 1, the authorization may disclose a quantity which differs from up to 1/10 of the prescribed quantity. If the medicinal product belongs to the Delivery Group "B", cf. § 63, paragraph 4, or if the medicinal product is not prescriptive, the pharmacy may give up a package size that differs from up to 1/4 of the prescribed quantity. If the medicinal product belongs to the Delivery Group "BP" or "BPK", cf. § 63, paragraph Twelve and the first. 14, the pharmacy and the holder of the person in section 1 (1). 1, the permission referred to above shall be handed over to a wrapper which differs from up to 1/4 of the prescribed quantity.

Paragraph 2. Where the prescription originator at the underscore of the prescribed quantity has indicated that it is not permitted to be deviated, the pharmacy and the holder of the person referred to in paragraph 1 (2) shall be waistdated. 1, the authorization shall disclose a quantity corresponding to the ordination. Deviates the prescribed quantity from the pacing sizes found in the market, the pharmacy and the holder of the quantity in section 1 (2). The permit shall be handed over to 1 or the packages nearest to the prescribed quantity, as set out in the case of the said body. paragraph 1.

Paragraph 3. If the prescription originator has indicated that the prescription may be dispensated several times with a specified time-space, and the pharmacy and the holder of the person in section 1 (2). 1, the authorisation referred to above shall supply a quantity deviant from the prescribed quantity, or shall be extended to a proportionate time between the time limit.

Paragraph 4. The total quantity supplied shall correspond to the total amount of the prescribed quantity.

§ 32. If a medicinal product is to be dosed, cf. the notification of dose dispensation of medicinal products, the pharmacy may supply the quantity of medicinal products which, according to the dose card, shall be used during the period to which the dose is being dosed.

§ 33. Medicinal products for individuals or animals must be of the pharmacy or holder of the person referred to in section 1 (1). The following information shall be provided on the packaging referred to in 1,

1) The name or the name of the person or the name of the animal and its owner, and the CHR number of animals in animal animals with CHR number.

2) The child's age, if the child has not yet been provided with a health insurance certificate.

3) Usage instructions, cf. § 8 (3) Paragraph 17 (1) and section 17 (3). 4.

4) Date of the expedition.

5) The name of the pharmacy or the holder of the one in section 1 (1). 1, mentioned permission.

Paragraph 2. Medicinal products for use in the prescription of the receptor shall be to the pharmacy or holder of the person referred to in section 1 (2). The authorisation referred to in paragraph 1 shall be subject to authorization. 1, no. 4 and 5, mentioned information and name of the receptor.

Paragraph 3. Medicinal products for distributive doctors and veterinarians and not distributive doctors to pass the dispensary to the pharmacy or holder of the person in section 1 (1). The authorisation referred to in paragraph 1 shall be subject to authorization. 1, no. The information referred to in 4 and 5.

Paragraph 4. The information referred to in paragraph 1. 1-3 shall be subject to the pharmaceutical packaging, easily legibly, printed or typed on a label placed on the packaging. If the packaging is made up of several parts, the label shall, as far as possible, be placed on the inside wrapping.

Paragraph 5. The rules of paragraph 1. Paragraph 1-4 does not apply to dosisdispensed medicinal products.

§ 34. If a medicinal product after the prescription of the prescription originator must appear with a warning that it may reduce the ability to drive motor vehicles or operate dangerous machinery, cf. Section 14, paragraph 14. 3, the pharmacy shall ensure the warning symbol in the form of a red, equitable triangle, cf. notification of the labelling of medicinal products.

$35. The chemist and the holder of the one in section 1 (1). On each expedition of a prescription, a prescription shall be indicated at the prescription :

1) Date of expedition.

2) Delivered or sepposed medicinal product.

3) Delivered or sepated quantity.

4) The name of the pharmacy or the holder of the one in section 1 (1). 1, mentioned permission.

§ 36. In conjunction with a prescribed medicinal product, the Customer must have provided a cartridge or, if this is not possible, other documentation of the following information :

1) Customer's CPR no. or fictional CPR No, cf. the statement on the Central Register of the Medicines of Medicinal Products (CTR).

2) Dispatch number.

3) Date of expedition.

4) The name of the apocalypse.

5) Medicinal Product (name).

6) Consumer price is divided into a patient share and public shares, including pharmaceutical supplements from the region.

7) Offer price.

8) Balance in CTR inferred in grant prices before the expedition of the prescription.

9) Commitment Period in CTR.

§ 37. Where no more medicinal products are available on a prescription, the pharmacy or the holder of the person referred to in paragraph 1 (1). 1, mentioned permission to the prescription for the cancellation of the cancellation of the authorization.

Paragraph 2. Telephone and fax receptees are not covered by the provision in paragraph 1. 1, unless they are delivered from the pharmacy or holder of the one in section 1 (1). 1, mentioned permission.

Paragraph 3. The chemist and the holder of the one in section 1 (1). On request, 1, the said authorization must be supplied to the Customer on request. If a prescription contains the receptissuer ' s CPR No, this must be deleted before the prescription blanquette is provided.

§ 38. The pharmacy must supply the cheapest medicinal product in the group of pharmacists for medicinal products, cf. Article 60 (3) of the medicinal product. 1, and by vaccines, as provided for in Annex 1 or Annex 2, replace the prescribed medicinal product (substitution).

Paragraph 2. Includes the ordination of several medicinal products with the same name (direct negotiated and parallelimported). 1 corresponding use.

Paragraph 3. The provision in paragraph 1 shall be 1, shall not apply if the prescription of the prescription has been explicitly stated at the prescription, that no substitution has to be made, cf. § 42, paragraph. 1.

Paragraph 4. The provision in paragraph 1 shall be 1 may be departed if one of the following conditions is met :

1) The price differential between the cheapest medicinal product in the group and the prescribed medicinal product is less than :

a) 5 kris if the cheapest medicinal product in the group will cost 100 kr. or thereunder,

b) 5%. the price of the cheapest medicinal product, provided that the cheapest medicinal product in the group costs more than 100 kris but less than 400 cranes or

c) 20 kris if the cheapest drug in the group is 400 kr. or over there.

2) In the case of dose dispensation of medicinal products for naming users, a particular situation is where doses of the cheapest medicinal product in the group cannot be carried out in a machine field, cf. The Article 11 (1) of the apothecary. 1, no. 11.

3) In the case of dose dispensation of medicinal products for patients processed in the primary sector, cf. notification of dose dispensation of medicinal products, section 1 (1). 2, no. 3, a situation in which the price differential between the cheapest medicinal product in the group and the prescribed medicinal product is less than 10%. in the case of the cheapest pharmaceutical unit price in the group, regardless of the package size.

Paragraph 5. In the calculation of paragraph 1, 4, no. 1, the consumer price is used, cf. the notice of the calculation of consumer prices etcetera on medicinal products. Includes the ordination of several medicinal products with the same name (direct negotiated and parallelized), the price difference shall be calculated in relation to the prescribed medicinal products which the pharmacy intends to hand out.

Paragraph 6. Notwithstanding the provisions of paragraph 1 1-5 may require the user to be supplied with the prescribed medicinal product or any medicinal product in the group of medicinal products, which, according to Annex 1 or Annex 2, replace the prescribed medicinal product. However, this does not apply if the prescription originator has expressly stated on the prescription that no substitution should be made, cf. § 42, paragraph. 1. For the dose dispensation of medicinal products to named users, the desire to have a particular medicinal product provided in accordance with the same system shall be provided for in accordance with the death certificate. 1. pkt., be submitted by submission of order or reorder to the receptionist dispensary.

§ 39. If it is cheaper for the user to be provided the prescribed medicinal product or a medicinal product that can replace the prescribed medicinal product, cf. § 38, paragraph. 1, in the form of several duplicate packs, the pharmacy must inform the user of it, cf. however, paragraph 1 Two and four. The user can choose to provide the prescribed wrapper size or more smaller packages.

Paragraph 2. The pharmacy shall be unable to inform the user after paragraph 1. 1 if :

1) the price differential between the prescribed pacing size and several smaller packs shall be less than 5 kroner, or

2) the provision of a number of smaller packages entails a significant risk of misusing of the medicinal product incorrectly.

Paragraph 3. The provisions of section 31 concerning the amount of the quantity supplied may differ from the prescribed shall also apply to the supply of multiple smaller packs pursuant to paragraph 1. 1.

Paragraph 4. The provision in paragraph 1 shall be 1-3 does not apply to medicinal products in the extradition group "HF", "HF", "HV", "BEGR", "A § 4-BEGR", " premix, "AP", "BP", and delivery group "APK" and "BPK" when the medicinal product is extraditable to the processing of production animals.

§ 40. If the prescribed medicinal product is included in the medicines at the delivery group "HF" and "HX", the pharmacy shall supply the cheapest medicinal product in the group of medicinal products, which, according to Annex 1 and Annex 2, can replace the prescribed medicinal product, cf. however, paragraph 1 3.

Paragraph 2. Is the prescribed medicinal product included in Medical Prices for Delivery ' s Delivery Group premix, "AP" or "BP" or "B" or "BPK" when it is delivered to the processing of the production animals, the pharmacy and the holder of the person in section 1 (1). The authorization shall be handed over 1, any medicinal product in the group of medicinal products listed in Annex 1 or Annex 2 to replace the prescribed medicinal product, cf. however, paragraph 1 3.

Paragraph 3. The chemist and the holder of the one in section 1 (1). However, a substitution may not, however, be substituted if the receptor has expressly stated on the prescription that this must not be carried out, cf. § 42, paragraph. 1.

§ 41. If a medicinal product prescribed for dose dispensation is both in the parking sizes recorded in the medicines at the delivery group "HF" or "HX" and the wrapping sizes that are reserved for the apothecary, the prescription shall be displeted for : the provisions of section 38.

§ 42. If the prescription at the prescription of the prescription has been indicated : 'Own S `', the pharmacy and the holder of the person in section 1 (1). The authorization shall not substitutes the prescribed medicinal product with another medicinal product.

Paragraph 2. Includes the ordination of more medicinal products with the same name (direct negotiated and parallelimported) without at the prescription being made a clear choice of preparation, including in the case of an indication of retailer or item number, the pharmacy and the holder of the certificate, in section 1 (1). The said licence shall be excluded from the drawing up of the phrase.

Paragraph 3. The Receptor ' s deductions of substitution shall not affect access to the provision of the prescribed medicinal product in several duplicate packs pursuant to section 39 (4). 1.

§ 43. The chemist and the holder of the one in section 1 (1). 1, mentioned permission shall write down telephone prescriptions on the label labeled "Pet Prescription".

Paragraph 2. The chemist and the holder of the one in section 1 (1). 1, the permit granted may only express telefax and telephone receptors once. However, pharmacies do not apply to methadone to patients for long-term care, cf. Section 15 (3). 4.

Paragraph 3. The chemist and the holder of the one in section 1 (1). 1, allow only telefax receptees received by one of the apothecary of a pharmacist unit or by the company address of the holder of the authorization holder.

Chapter 6

Retention and reporting of medicinal products which are eup-acting medicinal products

§ 44. Recepter on medicinal products subject to particular surveillance shall be kept at the pharmacy for at least 1 year after they have been expended. Instead of the original prescription, the pharmacy will keep a copy of the prescription inat. expedition information.

Chapter 7

Medicine Requests

§ 45. For pharmaceutical requisitions, requests are understood in a pharmacy or a hospital-mac of :

1) Medicinal products for medicinal products (central stockpiles in hospitals and other treatment institutions).

2) Receptionable medicinal products for medical departments and departments of similar institutions.

3) Medicinal Products for Receptionable Medicines

a) the processing facilities of the municipal management board for drug addicts, cf. Article 143 of the health officer, and

b) the processing sites of the local authorities, regional councils or private institutions, as the local authorities have concluded agreements with which the medical treatment of drug addicts is treated.

4) Medicinal products for the specific purposes referred to in § § 52-62.

§ 46. Medicine requisitions must be provided with the date, signature and printed or stamped information on the requestor (depots, department, etc.), name, address and telephone number. Medicine requisitions from medical or medical care departments must also be taken to the hospital ' s health code or medical care-based code.

Paragraph 2. Signature of the in section 45, no. However, the requisitions may be omitted from 1, 2 and 3 where the request is made by means of a drug-requisition system which, in agreement between the pharmacy or the hospital and the person responsible for the requisition, is designed in such a way as to enable the requisitioning of the requisition ; can be carried out in a reassuring manner. However, the requisitions of medicinal products covered by Section 4 must, however, always be provided with the signature of the requestor.

Paragraph 3. Medicine requisitions must contain the information referred to in section 7 (4). 1.

§ 47. They're in section 45, no. 1, 2 and 3 medical requisitions mentioned shall be made in writing, electronically, telefax or telephone.

Paragraph 2. They're in section 45, no. 4, the med-requisitions referred to in section 52, section 54, section 55, section 57, § 58, § 59, and § 62.

§ 48. In the case of electronic transmission, recording or sending over telefax, the provisions of section 20 (2) shall apply. 2 and 3, section 22 (3). Article 23 (2) and section 23 (1). 3, equivalent.

§ 49. They're in section 45, no. 1, the requisitions of requisitions may be submitted only by the edict of the depot or proxy.

Paragraph 2. They're in section 45, no. 2 and 3. Requisitions must be given by a doctor or a dentist.

Paragraph 3. By way of derogation from paragraph 1 2 can the doctor or dentist who are responsible for the department e.l. , however, provide that the requisition of medicinal products not subject to particular surveillance in accordance with section 4 of a specific scope may be carried out by an authorised person who is not a doctor or a dentist.

Paragraph 4. They're in section 45, no. 4, mentioned requisitions may be given by midwives, nurses, toothpicks, masters and shipowners, the manufacturers of the lifeboats, the managers of service stations carrying out the rescue boats and rafts, persons authorised to : obtain medicinal products for ambulances, as well as the managers of undertakings concerned with welding work, cf. § 52, § 54, § 55, § 57, § 58, § 59, and § 62.

$50. The pharmacy or hospital must organize procedures and routines in such a way as to ensure that there is sound control and security of the expedition of the med requisitions, and that the recipient is informed of the delivered necessary, medicinal products ' use, etc., of Medicine Requests are covered by the rules in section 26, section 27, paragraph 1. 3 and paragraph 1. 4, and Section 31 (3). 1. Section 31 (1). 1, however, do not apply to shipments to ship medicine coffins.

Paragraph 2. If a medical requisition is not drawn up in accordance with the provisions of this chapter, the pharmacy or the health care records shall seek this out. If any errors or defects have been undispuated or unquestionable, the requisition must not be disputing, unless :

1) Whereas it must be assumed that one or more patients suffer serious health damage if the requisition is not disputing and the treatment of patients must therefore be exposed ; or

2) there is no reasonable doubt as to the content of the requestor to provide the requisition.

Paragraph 3. The pharmacy or the carcass must be able to document the establishment in accordance with paragraph 1. 2. The documentation must be stored in the pharmacy or the hospital records for three years.

§ 51. Medicine requisitions must be processed by the pharmacy or the orderby pharmacy with the name of the pharmacy and date of the expedition.

Paragraph 2. The medicinal products must be in the name and date of the dispensary of the pharmacy or the orderby of the orderby of the orderby.

Paragraph 3. Medicine requisitions only have to express themselves once.

Requisitions for Special Purpose

Jor-mothers

§ 52. midwives can requisition the following medicinal products to use in practice :

1) Tablets containing methyl ergometry 0,125 mg.

2) Injector fluid containing methylometry 0,2 UG/ML.

3) Injector fluid containing oxytocin 10 /ml.

4) Injector fluid containing mepivacain 5 mg/ml and 10 mg/ml.

5) Injection fluid containing phytomenadion 10 mg/ml in ampule 0,2 ml ampule.

Paragraph 2. The midwives may, exceptionally, obtain the requisitors in paragraph 1. 1 mentioned medical telephonic. The provisions of section 23 (4). 2 and 3 shall apply mutatis mutis.

§ 53. They in section 52, paragraph 1. The medicinal product referred to in paragraph 1 shall be supplied to the pharmacy :

1) Earthmother's name.

2) The name of the apocalypse.

3) Date of expedition.

4) The endorsement : 'For use in practice'.

Nurses

§ 54. Nurses may, in writing, obtain adrenaline injector 1 mg/ml in ampuller a 1 ml per litre into practice.

Paragraph 2. The one in paragraph 1. The medicinal product mentioned shall provide the pharmacy with the following information :

1) The nurse's name.

2) The name of the apocalypse.

3) Date of expedition.

4) The endorsement : 'For use in practice'.

Tandcarers

§ 55. Authorized orthodoners with access to self-employed activities and to initiate infiltration analgesi may as part of the exercise of the orthodorship in writing to obtain the following medicinal products for use in practice :

1) Local-alanalgetics for injections containing mepivacain without a vasoconstrictor : injection fluid 30 mg/ml., tubule a 1,7 ml or 1,8 ml.

2) Premise algetics for injections containing lidocain, tilated vasoconstrictor (catechs) : injection of 2 pct., 1 ml containing 20 mg of lidocaine and 12,5 micrograms of adrenaline, tubule a 1,8 ml of epinephrine.

3) " Local " for injections containing mepivacain, tilated vasoconstrictor (catechs) : Injector liquid, 1 ml containing 20 mg mepivacain and 10 micrograms of adrenaline, tubule a 1,7 ml of adrenaline.

4) " Local " for injections containing price casseine, adjacent vasokonstriktor (felypressin) : Injection fluid 3 pct., 1 ml containing 30 mg of price locaine and 0,54 micrograms of field-tank, tubule a 1,8 ml

5) " Local " for injections containing arcain, added adrenaline : injection fluid 4 pct., 1 ml containing 40 mg of articain and 5 micrograms of adrenaline, tubular á1,7 ml.

6) " Local " for injections containing arcain, added adrenaline : injection flux 4%, 1 ml containing 40 mg of arcain and 10 micrograms of adrenaline, tubule a 1,7 ml.

7) Adrenalin injector 1 mg/ml. in ampuller a 1 ml.

8) Preparations containing sodium fluoride :

a) Dental suspension 50 mg of sodium fluoride / ml.

b) Dental suspension in varnish containing 60 mg of sodium fluoride / ml and 60 mg of calcium fluoroxide / ml.

c) Solution for mapologising 0,2%. Sodium fluoride.

d) Dip-up of teeth 2%. Sodium fluoride.

Paragraph 2. Authorized orthodoners with access to self-employed activities without the right to initiate infiltration analgesi may as part of the exercise of the orthodonship in writing in writing (s) in writing (s). 1, no. 8, mentioned medicinal products for use in practice.

§ 56. The medicinal products referred to in section 55 shall provide the pharmacy with the following information :

1) The name of the dentist.

2) The name of the apocalypse.

3) Date of expedition.

4) The endorsement : 'For use in practice'.

Shipdrivers, shipowners and manufacturers of lifeboats and other parts of the ship.

§ 57. Shipdrivers and shipowners may, in writing, obtain prescription medicinal products for medicinal products to be provided by their vessels in accordance with the applicable rules.

§ 58. Manufacturers of lifeboats and rafts and executives of service stations carrying out lifeboats and rafts, in writing and against the presentation of the authorisation from the Board of Health Requesting medical prescription medicinal products to be prescribed for medicinal products, lifeboats and rafts according to the applicable rules shall be provided.

Paragraph 2. Requisitions of medicinal products for lifeboats and rafts shall contain information about the lifeboat or naval (s) of the lifeboat and the number.

$59. Regions and municipalities and establishments which, by agreement, provide for ambulances available for the supply of ambulances belonging to the persons concerned in writing to the persons listed in writing in the Annex to the Scheduling Order ; the health alert and the pre-emergency preparedness and the training of paramedics and other medicinal products.

Paragraph 2. The requisition of medicinal products under paragraph 1. 1 may only be carried out by persons on which the regional council, the local authority board or its management authority has authorized it. The Committee of the Regions, the municipality Management Board or its Management Board shall notify the pharmacy in writing of who is empowered to obtain medicinal products in the region, the municipality or the undertaking ' s behalf.

§ 60. The pharmacy must supply the medicinal products delivered under the request of Section 57, Clause 58 and Section 59, with information on the name and date of the expedition and, as regards the medicinal products provided in sections 57 and section 58, as well as possible ; specific information required by applicable rules for the supply of medicinal products by ships.

§ 61. Expedited medical requisitions to ship medicine coffins must be kept at the pharmacy for 2 years.

Welding Companies

§ 62. Companies engaged in welding work may obtain an eye-saloe of cinchocain 0,5%. in endosiscontainers.

Paragraph 2. The pharmacy must provide the medicinal product to be provided with information on the name of the pharmacy and date of the expedition.

Chapter 8

Delivery Groups

§ 63. The Board of Health shall share prescription-only medicinal products in the following groups :

1) Delivery group "A-4".

2) Delivery group "A".

3) Delivery group "B".

4) Delivery group "BEGR".

5) Delivery group "NB-S".

6) Delivery group "A-4-BEGR".

7) Delivery group "A-4-NB-S".

8) Delivery group "R".

9) Delivery Group " premix".

10) Delivery group "AP".

11) Delivery group "BP".

12) Delivery group "APC".

13) Delivery group "BPK".

14) Delivery group "GA".

15) Delivery group "GB".

Paragraph 2. Medicinal products in the extradition group "A § 4" may be given only once after the same prescription, cf. however, section 15.

Paragraph 3. Medicinal products in the extradition group "A" may only give out once in accordance with the same prescription, unless the extradition occurs in several minor portions at a time.

Paragraph 4. Medicinal products in the Delivery Group "B" must be given once again after the same prescription, unless the prescription originator has indicated on the prescription, how many times and with which additional extradition shall take place.

Paragraph 5. Medicinal products in the extradition group "BEGR" the pharmacy must be handed over to hospitals. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' A `.

Paragraph 6. Medicinal products in the extradition group ' NB-S ` must be given only to hospitals or after the prescribed of specific specialist doctors. The Board of Health shall lay down for each medicinal product, which specialists may prescribe the medicinal product. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' A `.

Paragraph 7. Medicinal products in the Delivery Group "A-4-BEGR" must be handed over to hospitals only. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' A to 4 `.

Paragraph 8. Medicinal products in the Delivery Group "A-4-NB-S" must be given only to hospitals or after the prescribed of specific specialist doctors. The Board of Health shall lay down for each medicinal product, which specialists may prescribe the medicinal product. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' A to 4 `.

Niner. 9. Doctors in Delivery Group "R" are subject to a risk management program, cf. the section 62 of the medicinal product, and must be prescribed and provided accordingly. The detailed rules for the risk management programme are available in the area of the health management network. A medicinal product in the extradition group ' R ` shall be delivered in accordance with the provisions laid down in the case of the medicinal product, in accordance with the provisions laid down in the medicinal product. paragraph 1.

Paragraph 10. Medicinal products in the Delivery Group ' premix ` shall have to the pharmacy and the holder of the person in section 1 (1). The authorization alone shall be handed over from a veterinarian to feed mills having the authority of the Ministry of Health to produce feed medicinal products, in accordance with the order of the animal ' s veterinary medicinal product. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' B `.

Paragraph 11. Medicinal products in the delivery group ' AP ` shall be handed down to the pharmacies which have notified the Health Service notice after paragraph 12 (a) (1) (a). 1, in the case of apothecary, and of holders of the one in section 1 (1). 1, mentioned permission. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' A `.

Nock. 12. Medicinal products in the delivery group ' BP ` shall be handed down to the pharmacies which have notified the Board of Health, in accordance with section 12 (a) (1) (a). 1, in the case of apothecary, and of holders of the one in section 1 (1). 1, mentioned permission. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' B `.

Paragraph 13. Medicinal products in the extradition group ' APC ` may, in the use of production animals, only be handed down to the pharmacies which have notified the Board of Health, in accordance with section 12 (a) (1) (a). 1, in the case of the apothecary, and by holders of the one in section 1 (1). 1, mentioned permission. This is a condition which, in order to make it legal, is that the prescription has been applied to production animals. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' A `.

Paragraph 14. Medicinal products in the Delivery Group "BPK" must, by means of production animals, only be handed down to the pharmacies which have notified the Board of Health, in accordance with section 12 (a) (1) (a). 1, in the case of the apothecary, and by holders of the one in section 1 (1). 1, mentioned permission. This is a condition which, in order to make it legal, is that the prescription has been applied to production animals. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' B `.

Paragraph 15. However, medicinal products in the supply groups ' AP ' and ' BP ` for horses or rabbits which are not kept for commercial purposes, including the production of an eye, may also be handed out by pharmacies which have not given the Board of Health notice in accordance with section 12 (a) (1) (a). 1, in the case of apothecary.

Paragraph 16. Medicinal products in the extradition group "GA" must be handed down to pharmacies and holders of the one in section 1 (1). 2, mentioned permission. The medicinal products shall be provided in accordance with the provisions of the medicinal products in the extradition group ' A `.

Paragraph 17. Medicinal products in the Delivery Group "GB" must be handed out to pharmacies and holders of the one in section 1 (1). 2, mentioned permission. The medicinal products shall be supplied in accordance with the provisions of the medicinal products in the Delivery Group B.

§ 64. Medicinal products that are not subject to prescription in section 2 (2). 1, or Section 3, and as prescribed on prescription, shall be supplied in accordance with the provisions of the Delivery Group ' B `.

§ 65. Medicinal products for which no marketing authorisation has been issued, including the use of the medicinal products, shall be supplied in accordance with the provisions of the extradition group ' A `, cf. however, paragraph 1 Two, and § 66.

Paragraph 2. The people in paragraph 3. 1 of the medicinal products referred to above shall be supplied in accordance with the provisions of the extradition group ' A section 4 ` if they contain :

1) euphoria substances included in Appendix B of Annex 1 to the publication of eup-inisining substances, in quantities not exempt from the provisions of that notice ;

2) possible salts and simple derivatives with similar properties as those in paragraph 1. 1 mentioned euphoria ; or

3) substances included in Annex 3 to this notice.

§ 66. In determining which medicinal products are to be assigned to extradition group "BEGR", "NB-S", "A § 4-BEGR" and "A § 4-NB-S", the emphasis shall be placed in particular on the medicinal products ;

1) have special pharmacological properties or, in the interest of public health, the treatment of hospitals in hospitals,

2) be used for the treatment of diseases which are diagnosed in hospitals, etc., or

3) irrespective of the fact that they are intended for the outpatient use, a special expertise and special supervision requires special expertise.

§ 67. It is apparent from Medicine Prices which means the delivery group a medicinal product is located in, including which medical specialities have been added to prescribe medicinal products in the extradition group of 'NB-S' and ' A § 4-NB-S `.

Chapter 9

Revocation, non-security for payment and dispensation

§ 68. If a medicinal product is withdrawn from the market, the pharmacies and the holders of the person referred to in paragraph 1 (1). The said authorisation shall inform distributive doctors and veterinarians, hospitals and similar institutions for which they have deliveries.

§ 69. Pharmacies must supply medicinal products for a few days ' consumption without the safety of payment when the doctor prescribe the prescription,

1) the medical resources are needed immediately, and

2) who is expected to pay for the medicinal products later.

§ 70. The Board of Health may, in exceptional cases, and under conditions laid down in each individual case, the dispensers from the provisions of this notice or making a stricter requirement.

Chapter 10

Punishment and entry into force

§ 71. The penalty will be penalised by the penalty that violates paragraph 7. TWO, THREE. pkt., section 18, section 21, 2. pkt., section 23, paragraph. 4 and 5, section 24, section 2, section 25, paragraph. 2, section 26 (4). 1, sections 27-29, section 30 (4). Paragraph 2, section 31 (1). 2, section 33 (4). 1-4, section 34-36, section 37, paragraph. One and three, section 38, paragraph. Paragraph 1, section 39, paragraph. Paragraph 40, paragraph 40. 3, section 41, section 42, paragraph. Article 43 (1). Paragraph 1 and paragraph. TWO, ONE. pkt., and paragraph. 3, section 44, § 50, § 51, section 53, section 54 (5). 2, section 56, § 60, § 61, section 62, section 2, section 63, paragraph 1. 2-14 and paragraph 1. 16-17, section 64, section 65, § 68, and section 69.

Paragraph 2. Companies can be imposed on companies, etc. (legal persons) punishable by the rules of the penal code 5. Chapter.

§ 72. The announcement shall enter into force on 1. May 2012.

Paragraph 2. At the same time, notice No 1390 of 15. December 2011 on prescriptions.

---

Appendix 1

Appendix 1 contains a list of groups of medicinal products which may be substituted at the level of the medicinal product for the medicinal product, cf. § 38 and § 40

In the case of a device that lists of substitutable medicinal products are not recorded in Governing, this Annex shall not be included in Statestive. The appendix will be published on the Health Board's website and will be updated on every 14. the day, including the latest alteration and the time of its entry into force. The Annex shall be sent to an apothecary and others as an integral part of the price of medical services and may also be available when approached to the Health Services, Axel Heides Gade 1, 2300 Copenhagen S.

---

Appendix 2

Appendix 2 contains a list of groups of medicinal products which may be substituted for each other, cf. § 38

In the case of a device that lists of substitutable medicinal products are not recorded in Governing, this Annex shall not be included in Statestive. The appendix will be published on the Health Board's website and will be updated on every 14. Day. The Annex shall be sent to an apothecary and others as an integral part of the price of medical services and may also be available when approached to the Health Services, Axel Heides Gade 1, 2300 Copenhagen S.

---

Appendix 3

Substances which, without being included in Appendix B of Annex 1 to the Executive Order for the Euphoria are included, are covered by Section 65 (5) of the Concierent Notice. 2

Flunitrazepam

Modafinil

1) The commotion contains provisions that implement parts of Directive 2001 /83/EC of the European Parliament and of the Council of 6. November 2001 establishing a Community code of medicinal products for human use (EC Official Journal 2001, nr. L 311, s. Directive 67), as last amended by Directive 2011 /62/EC of the European Parliament and of the Council of 8. June 2011 (EU Official Journal) I'm 174 by 1. July, 2011, s. Directive 74-87) and parts of Directive 2001 /82/EC of the European Parliament and of the Council of 6. November 2001 establishing a Community Code of Medicinal Products for Veterinary Medicinal Products (EC Official Journal 2001 # L 311, s. Directive 1), as last amended by Directive 2009 /53/EC of the European Parliament and of the Council of 18. June 2009 (EU Official Journal # I'm 168 of 30. June 2009).